Abstract
Nosocomial infections are increasingly caused by fungi, with a more than 400% increase in fungal infections in academic teaching hospitals in the United States during the 1980s [1]. Currently, 7–10% of bloodstream infections in the United States are caused by Candida species [2–6]; with yeast accounting for 15% of bloodstream isolates in the period from 1992–1995 at the Johns Hopkins Hospital [7]. In 307 Candida bloodstream infections from 34 SENTRY participating centers, 80% of the bloodstream infections were nosocomial and 50% occurred in the intensive care unit (ICU) [8]. At the University of Iowa Hospitals and Clinics in the fiscal year 1992–1993 the rates of fungal infections in the medical and surgical ICUs were 6.95 and 5.25/1000 patient days, respectively [9]. The rate of bloodstream infections were compared between the fiscal years 1997–1998 and 1993–1994 and increased from 0.044/1000 patient days to 0.098, and the incidence of catheter-related urinary tract infections increased from 0.23/1000 patient days to 0.68 [9]. These studies probably understate the importance of Candida species as nosocomial pathogens in the ICU, as several autopsy studies have shown that Candida infections are often undiagnosed ante-mortem.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20: 1526–1530
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1989) Risk factors for hospital-acquired candidemia. Arch Intern Med 149: 2349–2353
Karabinis A, Hill C, Leclerq B, Tancrede C, Baume D, Andremont A (1988) Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 26: 429–432
Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL (1989) Risk factors for nosocomial candide-mia: a case-control study. Am J Med 87: 614–620
Komshian SV, Uwaydah A, Sobel JD, Crane LR (1989) Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 11: 379–390
Banerjee SN, Emori TG, Culver DH, et al (1991) Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. Am J Med 91 (suppl 3B): 86S - 89S
Maenza JR, Merz WG (1997) Candidemia: epidemiology and laboratory detection. Infectious Diseases In Clinical Practice 6: 83–88
Pfaller MA, Jones RN, Doern GU, Sader HS, Hollis RJ, Messer SA (1998) International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. J Clin Microbiol 36: 1886–1889
Berrouane YF, Herwaldt LA, Pfaller MA (1999) Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol 37: 531–537
Beck-Sague CM, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 167: 1247–1251
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148: 2642–2645
Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751–758
Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN (1994) Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 32: 975–980
Nolla-Salas J, Sitges-Serra A, Leon-Gil C, et al (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23: 23–30
Petri MG, Konig J, Moecke HP, et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 23: 317–325
Krause W, Matheis H, Wulf K (1969) Fungemia and funguria after oral administration of Candida albicans. Lancet 1: 598–599
Pfaller MA, Messer SA, Houston A, et al (1998) National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 31: 289–296
Pelz R, Lipsett PA, Swoboda S, et al (1998) Do surveillance cultures predict fungal infection in critically ill patients? Presented, Infectious Diseases Society of America
Dean DA, Burchard KW (1996) Fungal infection in surgical patients. Am J Surg 171: 374–382
Ascioglu S, DePauw B, Bennett JE, et al (1999) Analysis of definitions used in clinical research on invasive fungal infection (IFI): Consensus proposal for new, standardized definitions. 39th Inter-science Conference on Antimicrobial Agents and Chemotherapy, A1639 (Abst)
Ayeni O, Riederer KM, Wilson FM, Khatib R (1999) Clinicians’ reactions to positive urine culture for Candida organisms. Mycosis 42: 285–289
Edwards JE Jr, Body GP, Bowden RA, et al (1997) International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 25: 43–59
Pittet D, Garbino J (1995) Fungal infections in the critically ill. Curr Opin Crit Care 1: 369–380
Slotman GJ, Burchard KW (1987) Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 122: 147–151
Eggimann P, Francioli P, Bille J, et al (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27: 1066–1072
Pelz R, Hendrix D, Swoboda S, Diener-West M, Merz W, Hammond J, Lipsett P (1999) A double blind placebo controlled trial of prophylactic fluconazole to prevent Candida infections in critically ill surgical patients. Crit Care Med (in press)
Anaissie EJ, Darouiche RO, Abi-Said D, et al (1996) Management of invasive candidal infections: results of a prospective, randomized multicenter study of fluconazole versus Amphotericin B and review of the literature. Clin Infect Dis 23: 964–972
Rex JH, Bennett JE, Sugar, et al (1995) Intravascular catheter exchange and duration of candide-mia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis 21: 994–996
Solomkin JS, Flohr AM, Simmons RL (1982) Indications for therapy for fungemia in postoperative patients. Arch Surg 117: 1272–1275
Goff DA, Sierawski SJ, Fass RJ (1996) Cost analysis of Candida infection among surgical intensive care unit patients. Clin Drug Invest 12: 176–180
Pittet D, Tarara D, Wenzel R (1994) Nosocomial bloodstream infection in critically ill patient. Excess length of stay, extra costs, and attributable mortality. JAMA 271: 1598–1601
Pelz R, Hendrix CW, Swoboda S, et al (1999) Do fungal infections increase ICU cost? Abstract, 1999 meeting of the Surgical Infection Society
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lipsett, P.A. (2000). Fungal Infections in Critically III Surgical Patients. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2000. Yearbook of Intensive Care and Emergency Medicine, vol 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13455-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-13455-9_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-66830-5
Online ISBN: 978-3-662-13455-9
eBook Packages: Springer Book Archive